| Period Ending | Mar 31, 2012 | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 |
|---|
|
Total Revenue
|
6,268,000
|
6,034,000
|
6,006,000
|
6,173,000
| | Cost of Revenue | 2,950,000 | (740,000) | 2,879,000 | 2,720,000 | | |
Gross Profit
|
3,318,000
|
6,774,000
|
3,127,000
|
3,453,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 608,000 | 592,000 | 394,000 | 550,000 |
|
Non Recurring | 98,000 | 73,000 | 39,000 | 62,000 |
|
Others |
-
| 3,591,000 |
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
2,612,000
|
2,518,000
|
2,694,000
|
2,841,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 15,000 | 22,000 | 70,000 | 35,000 |
|
Earnings Before Interest And Taxes | 2,627,000 | 2,540,000 | 2,764,000 | 2,876,000 |
|
Interest Expense | 30,000 | 31,000 | 25,000 | 27,000 |
|
Income Before Tax | 2,597,000 | 2,509,000 | 2,739,000 | 2,849,000 |
|
Income Tax Expense | 1,139,000 | 949,000 | 1,087,000 | 1,111,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 1,560,000 | 1,641,000 | 1,775,000 | 1,819,000 | |
|
Non-recurring Events |
|
Discontinued Operations | (1,000) | (7,000) | (4,000) | (2,000) |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
1,559,000
|
1,634,000
|
1,771,000
|
1,817,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
1,559,000
|
1,634,000
|
1,771,000
|
1,817,000
|
|
0.60% Nasdaq